The Samuel Family Foundation continues generous support towards development of personalized immunotherapy cancer treatment
Dr. Jonathan Bramson’s group has recently received additional financial support from Mark Samuel and Kevin Sanford, both family members connected to the Samuel Family Foundation, to help bring their technology in cancer therapy from the lab into development for clinical use [...]
Dr. Jonathan Bramson’s group has recently received additional financial support from Mark Samuel and Kevin Sanford, both family members connected to the Samuel Family Foundation, to help bring their technology in cancer therapy from the lab into development for clinical use. The Samuel Family Foundation was founded in 2014, where $500, 000 were donated in an effort to help researchers at MIRC to develop a personalized immunotherapy cancer treatment. Just this month, the foundation has added another $250, 000, and Mark Samuel and Kevin Sanford have given an additional $200, 000 towards this investment in science. The Samuel Family Foundation supports work which is being carried out in the laboratory of Dr. Jonathan Bramson, and part of the funds also support immunological research trainees. Currently, Ksenia Bezverbnaya and Ken Mwawasi, MIRC trainees in the Bramson lab, are the two Samuel Family Scholars, however, more will be recruited. Family members associated with the foundation hope the gift will support bringing the early developmental work from the lab towards use in a clinical setting.
McMaster Immunology Research Centre, ResearchRelated News
News Listing
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
7 days ago
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
7 days ago